Daily ReportOct 6, 2026
Sepsis, October 6 edition
We read 25 papers and selected 3.
Summary
Today’s most impactful sepsis research spans a large multicenter real-world evaluation of early heparin exposure, genomic and functional characterization of overlooked neonatal pathogens, and a global systematic review defining the burden of obstetric sepsis in intensive care. Together, these studies emphasize the need to balance thrombo-inflammatory treatment benefits against bleeding risk, recognize antimicrobial-resistant coagulase-negative staphylococci as true pathogens, and address major inequities in maternal sepsis outcomes.
Research Themes
- Thrombo-inflammatory treatment and anticoagulation in septic shock
- Genomic and mechanistic characterization of neonatal sepsis pathogens
- Global epidemiology and inequities in obstetric sepsis
Selected Articles
1. Pathogenic traits of coagulase-negative Staphylococci and Mammalicoccus isolated from neonatal sepsis blood cultures in low- and middle-income countries.
This multicountry study analyzed 48 coagulase-negative staphylococcal isolates recovered as the sole pathogen from neonates with clinical sepsis in five low- and middle-income countries. Whole-genome sequencing and a Galleria mellonella model showed species-specific antimicrobial resistance and virulence, demonstrating that these organisms should not automatically be dismissed as contaminants.
Impact: The study challenges a common diagnostic assumption in neonatal sepsis and links genomic features to experimentally measured virulence. Its focus on low- and middle-income countries and antimicrobial resistance gives it particular relevance to global neonatal care and antibiotic stewardship.
Clinical Implications: Clinicians and microbiology laboratories should interpret coagulase-negative staphylococci from symptomatic neonates in the context of clinical signs, repeated cultures, species identification, and resistance profiles rather than uniformly labeling them contaminants. Species-specific resistance data may support more appropriate empiric and targeted therapy.
Key Findings
- Among 48 isolates, Mammaliococcus sciuri accounted for 40%, Staphylococcus haemolyticus for 31%, and Staphylococcus epidermidis for 23%.
- Multidrug resistance was present in 93% of S. haemolyticus and 91% of S. epidermidis isolates; 41.7% of all isolates carried mecA-positive SCCmec elements.
- S. haemolyticus caused higher Galleria mortality than S. epidermidis and M. sciuri, while S. epidermidis adherence-gene burden correlated positively with mortality.
Methodological Strengths
- Integration of whole-genome sequencing, resistome and virulome analysis, species-level characterization, and an in vivo Galleria mellonella virulence model.
- Sampling across seven hospitals in five low- and middle-income countries improves geographic relevance for underrepresented neonatal settings.
Limitations
- The isolate sample was relatively small, and the study lacked a comparator group of culture-negative neonates or isolates considered contaminants.
- Virulence was assessed in Galleria mellonella, which may not fully reproduce human neonatal immune responses or clinical disease severity.
Future Directions: Prospective neonatal surveillance should combine serial blood cultures, quantitative clinical adjudication, long-read or complete-genome sequencing, and clinical outcome data to define species-specific treatment thresholds and resistance-guided protocols.
Coagulase-negative staphylococci (CoNS) are increasingly recognised as neonatal pathogens in low- and middle-income countries (LMICs), yet are often dismissed as contaminants. We characterised the genomic landscape, antimicrobial resistance (AMR), and virulence of 48 CoNS isolates recovered as the sole pathogen from neonates with clinical sepsis across seven hospitals in five LMICs. Whole-genome sequencing determined sequence types, resistomes, and virulomes, whilst virulence was assessed using a Galleria mellonella in vivo model. Species identified included Mammaliicoccus sciuri (n=19; 40%), S. haemolyticus (n=15; 31%), S. epidermidis (n=11; 23%), S. saprophyticus (n=2), and S. xylosus (n=1). Multidrug resistance (≥3 classes) was pervasive in S. haemolyticus (93%) and S. epidermidis (91%), with 41.7% of all isolates harbouring mecA-positive SCCmec elements.
2. Burden of sepsis in obstetric critically ill patients: A qualitative systematic review.
This registered systematic review synthesized 25 observational studies involving 7,434,710 hospitalized obstetric patients and 3,593 obstetric ICU admissions for sepsis. Sepsis accounted for 5.7% of obstetric ICU admissions, septic shock occurred in 16.6%, median mortality was 4.6%, and outcomes differed markedly between high- and low-income countries.
Impact: The review provides the most comprehensive quantitative overview in the dataset of severe obstetric sepsis and highlights substantial international inequity. Its epidemiologic estimates can support maternal critical-care planning, surveillance systems, and targeted resource allocation even though the underlying evidence is observational.
Clinical Implications: Health systems should strengthen obstetric sepsis recognition, referral pathways, ICU capacity, and infection-prevention strategies, especially in low-income settings. The frequent respiratory, cardiovascular, genital, and urinary sources support broad surveillance and rapid source-focused management.
Key Findings
- Twenty-five observational studies were included from 5,847 screened records, covering 7,434,710 hospitalized obstetric patients and 3,593 obstetric ICU admissions for sepsis.
- Sepsis accounted for 5.7% of obstetric ICU admissions; septic shock occurred in 16.6% of cases, with respiratory and cardiovascular dysfunction commonly reported.
- Median mortality was 4.6%, with marked disparities between high- and low-income countries.
Methodological Strengths
- Prospectively registered PROSPERO review with a comprehensive search and a very large aggregated obstetric population.
- The review integrates epidemiology, organ dysfunction, infection sources, ICU utilization, and mortality while explicitly examining disparities by country income level.
Limitations
- All 25 included studies were observational, creating substantial risks of selection bias, confounding, heterogeneous case definitions, and inconsistent outcome reporting.
- The wide range of ICU admission incidence and mortality suggests important clinical and health-system heterogeneity that limits direct pooled comparisons.
Future Directions: International prospective obstetric sepsis registries should use standardized Sepsis-3-compatible definitions, maternal and perinatal outcomes, source-control variables, treatment timing, and resource-level indicators to quantify preventable mortality and guide equitable interventions.
BACKGROUND: Sepsis is a major contributor to maternal morbidity and mortality worldwide and represents one of the leading causes of intensive care unit (ICU) admission among obstetric patients. However, the burden and clinical profile of the most severely affected women remain incompletely defined. This systematic review aimed to estimate the epidemiology, characteristics, and outcomes of sepsis in critically ill obstetric patients. PATIENTS & METHODS: A comprehensive search was conducted for studies published between 2013 and 2025, including studies of women requiring ICU admission for sepsis during pregnancy or the post-partum. Following the screening process, 25 of the 5847 screened studies met the inclusion criteria. All were observational. The overall population included 7,434,710 hospitalised obstetric patients, including 3,593 obstetric ICU admissions for sepsis. The incidence of intensive care unit admissions ranged from 21 to 857 every 10,000 hospitalized obstetric patients and reached incidences of 11.3% among hospitalized obstetric patients with sepsis. Sepsis accounted for 5.7% of obstetric ICU admissions.
3. Early systemic heparin exposure is associated with lower mortality, reduced disseminated intravascular coagulation, and fewer thrombotic complications in septic shock.
In a retrospective multicenter TriNetX cohort, 105,472 patients with early systemic heparin exposure were compared with an equal propensity-matched cohort without exposure. Heparin was associated with lower mortality, reduced disseminated intravascular coagulation, and fewer thrombotic complications, but with increased renal dysfunction and bleeding-related adverse events.
Impact: The very large, multicenter analysis addresses a clinically important uncertainty in septic shock and identifies a potentially beneficial but clinically consequential anticoagulation strategy. The explicit benefit–harm trade-off provides a strong rationale for prospective randomized evaluation rather than immediate routine adoption.
Clinical Implications: Early heparin should not be routinely initiated solely on the basis of this observational association. Clinicians should consider bleeding risk, renal status, coagulopathy, and thrombotic phenotype, while prospective trials determine which septic shock subgroups may benefit.
Key Findings
- The study included 105,472 patients in each exposure cohort after multicenter propensity-based analysis.
- Early systemic heparin exposure was associated with lower mortality, including a reported mortality difference of 15.3% versus 20.8%.
- Heparin was associated with reduced disseminated intravascular coagulation and thrombotic complications but increased renal dysfunction and bleeding-related adverse events.
Methodological Strengths
- Extremely large multicenter electronic health record cohort with propensity score matching across demographics, comorbidities, infection features, and severity variables.
- Use of risk-based, time-to-event, and predefined 30-day outcome analyses enabled evaluation of both effectiveness and safety signals.
Limitations
- The retrospective observational design cannot establish causality and remains vulnerable to residual confounding and treatment-selection bias.
- The abstract does not provide detailed dosing, timing definitions, bleeding severity, or granular subgroup results needed to guide patient selection.
Future Directions: Prospective randomized trials should evaluate heparin against standard care using predefined thrombotic and bleeding phenotypes, dose and timing strategies, renal safety monitoring, and clinically meaningful mortality and organ-function outcomes.
INTRODUCTION: Septic shock is characterized by thrombo-inflammatory dysregulation and disseminated intravascular coagulation (DIC), contributing to organ failure and mortality. The clinical impact of heparin in septic shock remains uncertain. This study evaluated the association between early systemic heparin exposure and clinical outcomes. METHODS: A retrospective multicenter cohort study was conducted using the TriNetX federated electronic health record network. Adult patients with septic shock receiving early systemic heparin exposure were compared with patients without heparin exposure. Propensity score matching balanced demographics, comorbidities, infection characteristics, organ dysfunction markers, and severity-related variables. Outcomes included mortality, DIC, thrombotic complications, renal outcomes, hematologic complications, and bleeding-related events. Clinical outcomes were assessed over a predefined 30-day follow-up period using risk-based and time-to-event analyses. RESULTS: A total of 105,472 patients per cohort were included. Early systemic heparin exposure was associated with lower mortality (15.3% vs. 20.8%;